Dr. Reddys Laboratories Ltd.

BSE: 500124 | NSE: DRREDDY
Mid Cap | Pharmaceuticals & Drugs
1245.50
-24.30 (-1.91%)
< Home < Back

Dr. Reddy’s concludes acquisition of 100% stake in Imperial Credit

Date: 04-03-2017

Dr. Reddy’s Laboratories has completed the acquisition of 100% stake in Imperial Credit, a non-banking finance company (NBFC), based out of Kolkata, for a consideration of Rs 2.05 crore.

The acquisition process was consummated on receipt of applicable regulatory approvals. The company proposes to undertake the group’s captive financial activities through this entity.

Dr. Reddy’s Laboratories is a multinational pharmaceutical company based in Hyderabad, Telangana in India. It manufactures and markets a wide range of pharmaceuticals in India and overseas.